July 1, 2026 · Form 4 insider transaction
ANDREWS RONALD ASBURY bought 922 shares of Plus Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.; Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.